Jacob Van Naarden (Lilly Oncology)

Eli Lil­ly's Van Naar­den hands $380M cash to Flag­ship-backed up­start in ma­jor new on­col­o­gy deal

Jake Van Naar­den, who rules the on­col­o­gy roost at Eli Lil­ly, is back in the deal­mak­ing game.

Mon­day morn­ing he un­corked a deal to pro­vide …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.